Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

SHANGHAI, NANJING, China and PLEASANTON, Calif., /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, production, and ...

Creating a beautiful, thriving yard is a joy for any homeowner. Watching your flowers bloom and your lawn grow lush and green ...

Revitalize soil health in Gujarat's potato belt to sustain agri-industrial growth and ensure food system resilience.

Bicycle Therapeutics' strong cash position and planned workforce reduction extend the operational runway into 2028. See why ...

The "Titanium Energy Award・2025 Annual Hydrogen List (HEBL2nd)" for hydrogen technology innovation was announced on October 10, 2025, focusing on technological achievements in the hydrogen sector to ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical ...

The Composite Materials Handbook-17 is publishing new data and industry best practices, helping to fill the aerospace ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical research results of its novel B7-H3-targeting ADC (R&D code: 7MW3711) for multiple ...

Shares in diagnostic play Nexsen have traded as much as 47% higher after debuting on the ASX today, following an $8 million ...

Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response –OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd.